Replies to post #1806 on Biotech Values

[DewDiligence]

More on CJC:

>> The six percent nausea or vomiting is not an issue because exanatide has a higher rate. <<

I respectfully disagree. The dropout rate was 6% during the titration stage only –it will almost certainly be higher when the dropouts from the maintenance stage (which haven’t yet been disclosed) are added in.

>> amln talks about the lar but they never say anything, I don't think it works. <<

AMLN doesn’t talk much about Exenatide LAR because they have more pressing concerns, such as getting the Exenatide NDA submitted and dealing with the FDA’s issues on Simlyn. ALKS does most of the talking about LAR.